PDCD1 and colorectal cancer: Hu et al. applied PD-1 inhibitors (toripalimab) for preoperative neoadjuvant treatment of locally advanced or stage III colorectal cancer with MSI-H and found that 88% of patients had complete remission postoperatively 5.